Connection

Osman Celik to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Back to Details
This is a "connection" page, showing publications Osman Celik has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Osman Celik
Connection Strength
0.321
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  1. Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors. J Oncol Pharm Pract. 2020 Oct; 26(7):1676-1682.
    View in: PubMed
    Score: 0.321
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.